Skip to main content
NeuronFeed

Assort Health vs Hyro

Which Voice & Speech AI tool is better in 2026?

Assort Health

$98M

Hyro

$45M

Side-by-side

Verdict

Assort Health is the more established option (raised $98M); pricing is comparable on both sides.

Metric Assort Health Hyro
Taglinei
Foundedi 2023 2018🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 72🏆 67
Total fundingi $98M🏆 $45M
Latest roundi Series A Growth
Valuationi
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Assort Health and Hyro.

Capability Assort Health Hyro
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Assort Health

  • Has raised more capital ($98M vs $45M)
  • Higher Neuron score (72 vs 67)
  • Newer company (2023)

🔵 Strengths of Hyro

  • More mature (2018)

Which should you choose?

Choose Hyro if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Voice & Speech tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Assort Health if you want the most established option — it has raised $98M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Assort Health vs Hyro — which is better?

It depends on your priority. Assort Health has raised more capital and is the more established option; Hyro has broader feature depth. See the side-by-side table above.

Is Assort Health cheaper than Hyro?

No — Hyro's cheapest paid plan is Free, while Assort Health's is Free.

Do Assort Health and Hyro offer free plans?

Assort Health: Yes, has a free plan. Hyro: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.